MoneyWorks4Me

Lactose India informs about closure of trading window

19 Jan 2019 Evaluate

Pursuant to Code of Conduct for Prevention of Insider Trading of the Company, Lactose India has informed that the Trading Window shall remain closed for Directors, Officers and designated employees of the Company from 20th January, 2019 to 27th January, 2019 for the purpose of approval of re-appointment of Sangita Maheshwari (DIN: 00369898) as the Whole-time Director of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..